Shang Yuanyuan, Zhu Zhe, Zhang Yuanyuan, Ji Fang, Zhu Lian, Liu Mengcheng, Deng Yewei, Lv Guifen, Li Dan, Zhou Zhuqing, Lu Bing, Fu Chuan-Gang
Department of Colorectal Surgery, Department of General Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China.
Department of Radiation Oncology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China.
Cell Death Discov. 2023 Feb 2;9(1):42. doi: 10.1038/s41420-023-01339-8.
Resistance to radiotherapy remains a major unmet clinical obstacle in the treatment of locally advanced rectal cancer. Cancer stem cells (CSCs) are considered to mediate tumor development and radioresistance. However, the role of CSCs in regulating resistance to radiotherapy in colorectal cancer (CRC) remains largely unknown. We established two radioresistant CRC cell lines, HCT116-R and RKO-R, using fractionated irradiation. Analysis using miRNA sequencing and quantitative real-time PCR confirmed lower levels of miR-7-5p in both of the radioresistant cells compared to their parental cells. Subsequently, we validated that miR-7-5p expression was decreased in cancerous tissues from radiotherapy-resistant rectal cancer patients. The Cancer Genome Atlas (TCGA) database analyses revealed that low miR-7-5p expression was significantly correlated with poor prognosis in CRC patients. Overexpression of miR-7-5p led to a rescue of radioresistance and an increase in radiation-induced apoptosis, and attenuated the stem cell-like properties in HCT116-R and RKO-R cells. Conversely, knocking down miR-7-5p in parental HCT116 and RKO cells suppressed the sensitivity to radiation treatment and enhance cancer cell stemness. Stemness-associated transcription factor KLF4 was demonstrated as a target of miR-7-5p. Rescue experiments revealed that miR-7-5p/KLF4 axis could induce radiosensitivity by regulating CSCs in colorectal cancer cells. Furthermore, we used CRC tumor tissues which exhibited resistance to neoadjuvant radiotherapy to establish a patient-derived xenograft (PDX) mouse model. Tail vein injection of magnetic nanoparticles carrying miR-7-5p mimics into the PDX mice significantly inhibited tumor growth with or without irradiation treatment in vivo. Our current studies not only demonstrate an anti-cancer function of miR-7-5p in regulating CSC properties and radiosensitivity in colorectal cancer, but also provide a novel potential strategy for delaying or reverse radiation resistance in preoperative radiotherapy of CRC patients.
对局部晚期直肠癌的治疗而言,放疗抵抗仍然是一个尚未解决的主要临床障碍。癌症干细胞(CSCs)被认为介导肿瘤发展和放疗抵抗。然而,CSCs在调节结直肠癌(CRC)放疗抵抗中的作用仍 largely未知。我们使用分次照射建立了两种放疗抵抗的CRC细胞系,HCT116-R和RKO-R。使用miRNA测序和定量实时PCR分析证实,与亲代细胞相比,两种放疗抵抗细胞中miR-7-5p水平均较低。随后,我们验证了放疗抵抗的直肠癌患者癌组织中miR-7-5p表达降低。癌症基因组图谱(TCGA)数据库分析显示,低miR-7-5p表达与CRC患者的不良预后显著相关。miR-7-5p的过表达导致放疗抵抗的挽救和辐射诱导凋亡的增加,并减弱了HCT116-R和RKO-R细胞中的干细胞样特性。相反,在亲代HCT116和RKO细胞中敲低miR-7-5p会抑制对放射治疗的敏感性并增强癌细胞干性。干性相关转录因子KLF4被证明是miR-7-5p的靶标。挽救实验表明,miR-7-5p/KLF4轴可通过调节结直肠癌细胞中的CSCs诱导放射敏感性。此外,我们使用对新辅助放疗有抵抗的CRC肿瘤组织建立了患者来源的异种移植(PDX)小鼠模型。将携带miR-7-5p模拟物的磁性纳米颗粒尾静脉注射到PDX小鼠体内,无论体内有无照射治疗,均显著抑制肿瘤生长。我们目前的研究不仅证明了miR-7-5p在调节结直肠癌CSC特性和放射敏感性方面的抗癌功能,还为延缓或逆转CRC患者术前放疗中的放射抵抗提供了一种新的潜在策略。